Brief Description

Breast cancer is the leading cause of cancer deaths in women today. According to the World Health Organization (WHO), one in every 12 women have the risk of a breast abnormality. Early diagnosis is very critical to decrease mortality rates. We, at NIRAMAI, have developed a novel software-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable cancer screening tool that can be operated in any clinic. Our imaging method is radiation free, non-touch, not painful and works for women of all ages. The core technology of our solution has been developed using our patented machine learning algorithms for reliable and accurate detection of breast cancer. This unique solution can be used as a cancer diagnosis test in hospitals, for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas.

Year of Foundation - 2016

List of use case/product/solution - Thermalytix, SMILE-100, Fever Test

Description of use case/product/solution - Thermalytix: Artificial Intelligence (AI) powered computer aided diagnostic system that detects breast malignancy and generates a detailed interpretation report from thermal images for early detection of breast cancers.
SMILE-100: A computer aided visualization tool to assist thermologists in interpretation of breast thermograms.
Fever Test: An Artificial Intelligence (AI) tool that detects the persons with high temperature or abnormal respiratory rate or no mask.

Our customers - Health Care Global Cancer hospital, Apollo clinic, Bruhat Bengaluru Mahanagara Palike (BBMP) Hospital, Karnataka Cancer Society, Garima cancer foundation, CanProtect Foundation RMZ corp, Kotak Mahindra, Morgan Stanley

GPU infrastructure - Tesla T4

Software stack - TensorRT